Page last updated: 2024-11-10

13,14-dihydroprostaglandin f2alpha

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

13,14-dihydroprostaglandin F2alpha: RN given refers to (5Z,9alpha,11alpha,15S)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

13,14-dihydroprostaglandin F2alpha : A prostaglandins Falpha that is prost-5-en-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID52193891
MeSH IDM0087041

Synonyms (7)

Synonym
7-(3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl)-5-heptenoic acid
13,14-dihydrodinoprost
13,14-dihydroprostaglandin f2alpha
13,14-dihydro-pgf2-alpha
5-heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl)-
13,14-dihydroprostaglandin f2-alpha
prost-5-en-1-oic acid, 9,11,15-trihydroxy-, (5z,9-alpha,11-alpha,15s)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (77.78)18.7374
1990's3 (16.67)18.2507
2000's1 (5.56)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]